RDNT - RadNet Insider Trades Send A Signal | Benzinga
DAVID SWARTZ, Director at RadNet (NASDAQ:RDNT), reported an insider sell on June 12, according to a new SEC filing.
What Happened: SWARTZ's recent move involves selling 25,000 shares of RadNet. This information is documented in a Form 4 filing with the U.S. Securities and Exchange Commission on Wednesday. The total value is $1,518,841.
In the Thursday's morning session, RadNet's shares are currently trading at $61.75, experiencing a down of 0.0%.
Discovering RadNet: A Closer Look
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments; The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures, and Artificial Intelligence segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. The company derives a majority of its revenue from the Imaging center segment.
Breaking Down RadNet's Financial Performance
Revenue Growth: Over the 3 months period, RadNet showcased positive performance, achieving a revenue growth rate of 10.53% as ...